Fig. 2From: Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancerKinetics of the anti-EGF antibody titers and serum EGF concentration in patients. A significant inverse correlation was observed (Spearman rho = − 1.000, p < 0, 01) between the anti-EGF antibody titers and serum EGF concentration in patients treated with the vaccineBack to article page